OGC
ALT icon

One68 Global Capital’s Altimmune ALT Stock Holding History

One68 Global Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$122K Buy
+10,814
New +$127K 0.24% 96
2020
Q1 		– Sell
-13,756
Closed -$1K – 11
2019
Q4 		$1K Buy
+13,756
New +$25.4K ﹤0.01% 78

Other funds holding ALT

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

One68 Global Capital's ALT Position: Q4 2020 in Review

One68 Global Capital opened a new position in Altimmune (ALT) in Q4 2020: 10,814 shares worth $122K. The stake represents 0.24% of the portfolio and ranks #96 among its holdings. This is a return to the name: One68 Global Capital previously reported a position in ALT as recently as Q4 2019.

One68 Global Capital first reported a position in ALT in Q4 2019 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2020.

  • One68 Global Capital held 10,814 shares of Altimmune worth $122K as of Q4 2020.
  • Altimmune was a new One68 Global Capital position in Q4 2020.
  • Altimmune made up 0.24% of One68 Global Capital's portfolio in Q4 2020, its #96 holding.
  • One68 Global Capital first reported a position in Altimmune in Q4 2019 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held Altimmune as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.